Evolent Health

Evolent Health P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Evolent Health (EVH) as of Nov 3, 2026 is 8.02. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 16.59 — a change of -51.69% (lower).

P/CF

8.02

YoY

-51.69%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Evolent Health is 2025 8.02 . P/CF (Price-to-Cash-Flow Ratio) of Evolent Health was 2024 16.59 . It decreases by -51.69% lower compared to the previous year.

The Evolent Health P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
-15.08 USD
Jan 1, 2019
-7.30 USD
Jan 1, 2020
-19.19 USD
Jan 1, 2021
8.04 USD
Jan 1, 2022
-26.95 USD
Jan 1, 2023
2.18 USD
Jan 1, 2024
16.59 USD
Jan 1, 2025
8.02 USD
The Evolent Health P/CF history
YEARP/CFYoY
8.02-51.69%
16.59+659.83%
2.18-108.10%
-26.95-435.38%
8.04-141.87%
-19.19+162.84%
-7.30-51.57%
-15.08+35.38%
-11.14+27.01%
-8.77-44.16%
-15.70+278.71%
-4.15—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolent Health Stock analysis

What does Evolent Health do? Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry. Evolent Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolent Health stock

P/CF (Price-to-Cash-Flow Ratio) of Evolent Health is 8.02 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Evolent Health changed from 16.59 to 8.02, representing a -51.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Evolent Health since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Evolent Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Evolent Health

All Key Metrics — Evolent Health